CRLK1 Antibody

Shipped with Ice Packs
In Stock

Description

CRLK1 Antibody Development and Validation

The CRLK1 antibody was generated using a synthetic peptide corresponding to amino acids 385-400 of the CRLK1 protein conjugated with keyhole limpet hemocyanin (KLH) as the immunogen . Key validation data includes:

Validation ParameterExperimental Evidence
SpecificityNo cross-reactivity observed in crlk1 knockout mutants during immunoprecipitation
Subcellular LocalizationConfirmed plasma membrane localization using fractionation and Western blot
Cold ResponsivenessDetected increased CRLK1 protein levels after 1-hour cold treatment (4°C)

Key Research Applications

The antibody has enabled critical discoveries through these experimental approaches:

Protein Interaction Studies

  • Identified MEKK1 (MAP kinase kinase kinase 1) as a direct interaction partner via co-immunoprecipitation

  • Revealed calcium/calmodulin enhances CRLK1-MEKK1 binding affinity by 6.4-fold in GST pull-down assays

Signaling Mechanism Analysis

  • Demonstrated abolished MAP kinase activation in crlk1 mutants under cold stress

  • Showed 58% reduction in CBF1 and COR15a gene expression in mutants vs wild-type

Cellular Localization Mapping

  • Established CRLK1's plasma membrane localization through two-phase partitioning:

Cellular FractionCRLK1 Detection
CytosolicNegative
MicrosomalWeak
Plasma MembraneStrong

Critical Research Findings

The antibody facilitated these landmark discoveries:

  1. Cold-Induced Protein Regulation: CRLK1 protein levels increase 2.3-fold within 1 hour at 4°C

  2. Calcium Signaling Interface: Calcium/calmodulin binding increases CRLK1 kinase activity by 41%

  3. Genetic Pathway Connections: CRLK1 modulates:

    • MAPK cascade activation (p < 0.01 vs mutants)

    • ICE1 transcription factor stability

    • CBF/DREB1 cold response pathway

Experimental Performance Characteristics

ApplicationSensitivityKey Limitation
Western Blot1:5000Requires cold-treated samples
Immunoprecipitation1:100Needs >100 mg tissue input
ELISANot validatedN/A

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
CRLK1 antibody; At5g54590 antibody; MRB17.9Calcium/calmodulin-regulated receptor-like kinase 1 antibody; AtCRLK1 antibody; EC 2.7.11.1 antibody
Target Names
CRLK1
Uniprot No.

Target Background

Function
This antibody targets CRLK1, a protein essential for cold tolerance. CRLK1 functions by activating MAP kinase activity. Specifically, it phosphorylates and activates MEKK1 in response to cold stimuli through a calcium-dependent mechanism.
Database Links

KEGG: ath:AT5G54590

STRING: 3702.AT5G54590.2

UniGene: At.26329

Protein Families
Protein kinase superfamily, Ser/Thr protein kinase family
Subcellular Location
Cell membrane; Single-pass membrane protein. Endosome membrane; Single-pass membrane protein.
Tissue Specificity
Similar transcript expression levels in seedlings, roots, leaves, stems and flowers, and lower levels in siliques, but protein accumulates mostly in 7-day-old seedlings, old roots and young leaves and, to a lower extent, in young roots, old leaves, flower

Q&A

What is CRLK1 and why is it important in plant research?

CRLK1 is a novel calcium/calmodulin-regulated receptor-like kinase that plays a significant role in regulating plant cold tolerance. Research has established that calcium/calmodulin binds to CRLK1 and upregulates its activity. Gene knockout and complementation studies have confirmed that CRLK1 functions as a positive regulator of plant responses to chilling and freezing temperatures . CRLK1 is particularly important because it represents a critical link between calcium signaling and downstream MAPK cascades in cold stress response, making it a valuable target for understanding plant adaptation mechanisms to environmental stresses.

What are the key characteristics of CRLK1 antibodies?

CRLK1 antibodies are typically polyclonal or monoclonal antibodies raised against specific epitopes of the CRLK1 protein. High-quality CRLK1 antibodies demonstrate:

  • Specificity for CRLK1 without cross-reactivity to related kinases

  • Ability to detect native and denatured forms of the protein

  • Effectiveness in multiple applications including immunoprecipitation, Western blotting, and immunolocalization

  • Capability to distinguish between wild-type and mutant versions of CRLK1

The antibodies used in published research have successfully pulled down CRLK1 complexes from plant tissues after cold treatment, enabling the identification of interacting partners like MEKK1 .

What is the relationship between CRLK1 and the MAP kinase signaling pathway?

CRLK1 has been shown to interact with MEKK1, a member of the MAP kinase kinase kinase family, both in vitro and in planta . This interaction is significant because:

  • Cold-triggered MAP kinase activation observed in wild-type plants is abolished in crlk1 knockout mutants

  • Cold-induced expression levels of genes involved in MAP kinase signaling are altered in crlk1 mutants

  • CRLK1 appears to modulate cold acclimation through the MAP kinase cascade

These findings suggest that CRLK1 functions upstream of the MAPK cascade in cold stress signaling, linking calcium/calmodulin perception to MAPK activation .

How does calcium/calmodulin binding affect CRLK1 interaction with MEKK1?

This calcium/calmodulin-dependent enhancement suggests a regulatory mechanism where:

  • Cold stress triggers calcium influx

  • Increased calcium enables calmodulin binding to CRLK1

  • This binding induces conformational changes in CRLK1

  • The altered conformation increases CRLK1's affinity for MEKK1

  • Enhanced CRLK1-MEKK1 interaction activates downstream MAPK signaling

This molecular mechanism explains how plants translate calcium signals into MAPK pathway activation during cold stress responses.

What are the technical challenges in using CRLK1 antibodies for co-immunoprecipitation studies?

Researchers working with CRLK1 antibodies for co-immunoprecipitation face several technical challenges:

ChallengeCausePotential Solution
Low abundance of CRLK1 proteinLimited expression under normal conditionsPre-treat plants with cold (4°C) to increase CRLK1 protein levels
Weak interactions with partnersTransient or conditional interactionsInclude calcium and calmodulin in buffers to stabilize interactions
Background bindingNon-specific antibody interactionsUse crlk1 knockout mutants as negative controls
Complex stabilityInteractions may dissociate during processingUse chemical crosslinking before extraction
Post-translational modificationsChanges in phosphorylation stateInclude phosphatase inhibitors in extraction buffers

Successful co-immunoprecipitation studies, as demonstrated in the literature, typically include cold treatment of plants before protein extraction and carefully optimized buffer conditions that maintain calcium levels .

How can researchers differentiate between direct and indirect CRLK1 interactors?

Differentiating between direct and indirect CRLK1 interactors requires a multi-faceted approach:

  • In vitro binding assays: Direct interactions can be confirmed using purified recombinant proteins in GST pull-down assays, as was done for CRLK1 and MEKK1 .

  • Bimolecular Fluorescence Complementation (BiFC): This approach can validate direct protein-protein interactions in living cells. For example, BiFC vectors carrying CRLK1 and MEKK1 co-transfected into Arabidopsis protoplasts showed direct interaction on cell membranes and in intracellular vesicle-like structures .

  • Yeast two-hybrid screens: These can identify direct protein interactions but should be validated with other methods due to potential false positives.

  • Sequential co-immunoprecipitation: This technique can help distinguish primary from secondary interactors by using stringent washing conditions or sequential pull-downs.

  • Proximity-dependent labeling: Methods like BioID or APEX can identify proteins in close proximity to CRLK1 in their native cellular environment.

Each method has specific advantages for detecting different types of interactions and should be selected based on the research question being addressed.

What are the optimal conditions for using CRLK1 antibodies in Western blot analyses?

Optimal conditions for Western blot analyses with CRLK1 antibodies include:

ParameterRecommended ConditionRationale
Sample preparationCold-treated plant tissue (4°C for 1-2 hours)Increases CRLK1 protein expression
Extraction buffer50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100, protease inhibitorsMaintains protein integrity while extracting membrane-associated proteins
Sample loading50-100 μg total protein per laneEnsures detection of low-abundance CRLK1
Blocking solution5% non-fat dry milk in TBSTReduces background without affecting antibody specificity
Primary antibody dilution1:1000 to 1:5000Depends on antibody quality and specificity
Incubation conditionsOvernight at 4°CImproves signal-to-noise ratio
ControlsWild-type vs. crlk1 knockout extractsEssential for validating antibody specificity
Detection methodEnhanced chemiluminescenceProvides sensitive detection of CRLK1

Including wild-type and crlk1 knockout samples as positive and negative controls is critical for verifying antibody specificity and for interpreting experimental results accurately .

What approaches are recommended for studying CRLK1 phosphorylation states?

Studying CRLK1 phosphorylation states requires specialized techniques:

  • Phospho-specific antibodies: Development of antibodies that recognize specific phosphorylated residues on CRLK1 can help monitor its activation state.

  • Phos-tag SDS-PAGE: This technique can separate phosphorylated from non-phosphorylated forms of CRLK1, allowing visualization of multiple phosphorylation states.

  • In vitro kinase assays: Similar to methods used for studying OST1-mediated BTF3L phosphorylation , using purified CRLK1 with potential upstream kinases in the presence of [γ-32P]ATP can identify phosphorylation events.

  • Mass spectrometry: Phosphopeptide enrichment followed by LC-MS/MS analysis of immunoprecipitated CRLK1 can identify specific phosphorylation sites and their stoichiometry.

  • Mutagenesis studies: Site-directed mutagenesis of potential phosphorylation sites (Ser/Thr to Ala or Asp) can help determine the functional significance of specific phosphorylation events.

When studying CRLK1 phosphorylation, it's important to maintain phosphatase inhibitors in all buffers and consider the rapid and dynamic nature of phosphorylation changes during signaling events.

How can researchers effectively localize CRLK1 using immunofluorescence techniques?

Effective CRLK1 localization using immunofluorescence requires:

  • Sample preparation:

    • Fix tissue samples with 4% paraformaldehyde

    • Perform gentle cell wall digestion for plant tissues

    • Permeabilize with 0.1-0.5% Triton X-100

  • Antibody optimization:

    • Test different antibody dilutions (typically 1:100 to 1:500)

    • Include appropriate blocking (5% BSA or normal serum)

    • Use fluorophore-conjugated secondary antibodies with minimal channel overlap

  • Controls and validation:

    • Include crlk1 knockout tissues as negative controls

    • Consider co-localization with membrane markers (for cell membrane localization)

    • Use co-localization with vesicle markers to confirm intracellular structures

  • Imaging considerations:

    • Use confocal microscopy for improved spatial resolution

    • Capture z-stacks to visualize the full cellular distribution

    • Apply deconvolution to improve signal-to-noise ratio

  • Alternative approaches:

    • Consider using GFP-tagged CRLK1 for live cell imaging

    • Use BiFC to simultaneously visualize interactions and localization as demonstrated with CRLK1-MEKK1

CRLK1 has been shown to associate with MEKK1 both on cell membranes and in intracellular vesicle-like structures , so particular attention should be paid to these cellular compartments.

How can CRLK1 antibodies be used to investigate cold stress signaling pathways?

CRLK1 antibodies can be employed in multiple experimental strategies to investigate cold stress signaling:

  • Pathway component identification: Co-immunoprecipitation with CRLK1 antibodies followed by mass spectrometry can identify novel interacting partners in the cold response pathway. This approach has already revealed 12 potential interacting proteins including MEKK1, another unknown protein kinase, a type 2C phosphatase, and CaM .

  • Signaling kinetics: Western blot analysis of CRLK1 phosphorylation state following cold treatment can reveal the timing of CRLK1 activation in relation to other cold signaling events.

  • Tissue-specific expression: Immunohistochemistry with CRLK1 antibodies can reveal which tissues and cell types predominantly express CRLK1, providing insights into site-specific cold responses.

  • Biochemical complex characterization: Using native PAGE followed by Western blotting with CRLK1 antibodies can help characterize the composition and size of CRLK1-containing protein complexes under different conditions.

  • Genetic interaction studies: Comparing CRLK1 antibody pull-downs from wild-type plants versus various signaling mutants can help position CRLK1 within the signaling hierarchy.

These approaches have established that CRLK1 functions upstream of the MAPK cascade in cold stress signaling, with CRLK1 knockout mutants showing abolished MAP kinase activation in response to cold treatment .

What are the best approaches for studying the CRLK1-MEKK1 interaction dynamics?

To effectively study CRLK1-MEKK1 interaction dynamics, researchers can employ several complementary techniques:

  • Real-time interaction monitoring:

    • Förster Resonance Energy Transfer (FRET) with fluorescently tagged proteins

    • Split luciferase complementation assays for quantitative real-time measurements

    • Surface Plasmon Resonance (SPR) for in vitro kinetic measurements

  • Interaction domain mapping:

    • Deletion mutants to identify minimal interaction domains

    • Peptide arrays to pinpoint specific binding motifs

    • Alanine scanning mutagenesis of key residues

  • Calcium/calmodulin dependency:

    • Calcium chelators (EGTA) to inhibit interactions

    • Calmodulin antagonists to block enhancement effects

    • Calcium concentration titrations to determine threshold requirements

  • Spatial organization:

    • Super-resolution microscopy to visualize interaction sites

    • BiFC combined with organelle markers to identify subcellular compartments where interactions occur

    • Cell fractionation followed by co-immunoprecipitation

  • Temporal dynamics:

    • Time-course experiments following cold exposure

    • Temperature shift experiments to determine activation thresholds

    • Pulse-chase approaches to measure interaction stability

GST pull-down assays have already demonstrated that calcium/calmodulin dramatically increases the affinity between CRLK1 and MEKK1 , while BiFC has shown that these proteins associate both on cell membranes and in intracellular vesicle-like structures .

How can researchers use CRLK1 antibodies to study crosstalk between cold stress and other signaling pathways?

CRLK1 antibodies can be instrumental in investigating signaling crosstalk through these approaches:

  • Differential co-immunoprecipitation:

    • Compare CRLK1 interactome under cold stress alone versus combined stresses (e.g., cold+drought, cold+salt)

    • Identify condition-specific interaction partners

    • Map changes in interaction strength under different stress combinations

  • Phosphoproteomic analysis:

    • Immunoprecipitate CRLK1 under various stress conditions

    • Analyze phosphorylation patterns using mass spectrometry

    • Identify stress-specific phosphorylation sites that may regulate pathway specificity

  • Comparative expression analysis:

    • Use CRLK1 antibodies to quantify protein levels across stress conditions

    • Correlate CRLK1 protein abundance with expression of stress-responsive genes

    • Assess CRLK1 stability and turnover under different stress regimes

  • Hormone response integration:

    • Analyze CRLK1 complex formation after treatment with stress hormones (ABA, ethylene, etc.)

    • Map interactions between CRLK1 and hormone signaling components

    • Compare cold-induced MAP kinase activation in hormone signaling mutants

  • Multi-stress transcriptional response:

    • Chromatin immunoprecipitation (ChIP) of transcription factors following CRLK1 immunoprecipitation

    • Compare binding patterns and target genes under single versus combined stresses

    • Analyze expression of genes like RAV1, RAV2, and STZ whose expression levels are reduced in crlk1 plants after cold treatment

These approaches can help decipher how CRLK1 contributes to stress-specific responses versus general stress adaptation mechanisms in plants.

What are common problems when using CRLK1 antibodies and how can they be addressed?

IssuePotential CausesSolutions
Weak or no signal in Western blotsLow protein abundance; Protein degradation; Insufficient extractionIncrease protein loading; Add protease inhibitors; Cold-treat plants to increase CRLK1 expression; Optimize extraction buffer
Multiple bands in Western blotsSplice variants; Degradation products; Post-translational modifications; Cross-reactivityUse crlk1 knockout as negative control; Try different antibodies targeting different epitopes; Optimize extraction and sample preparation
Failed co-immunoprecipitationWeak or transient interactions; Unsuitable buffer conditionsAdd calcium and calmodulin to stabilize interactions; Use chemical crosslinking; Optimize salt concentration in wash buffers
High background in immunofluorescenceNon-specific binding; AutofluorescenceIncrease blocking time/concentration; Include additional washes; Use crlk1 knockout as control; Consider spectral unmixing to remove autofluorescence
Inconsistent precipitation efficiencyVariable antibody quality; Batch effectsUse antibody-conjugated beads for consistency; Standardize protocols; Include internal controls for normalization

When troubleshooting CRLK1 antibody applications, always include appropriate controls like using tissue from crlk1 knockout plants to confirm specificity, as demonstrated in published research .

How can researchers validate the specificity of their CRLK1 antibodies?

Comprehensive validation of CRLK1 antibody specificity should include:

  • Genetic controls:

    • Compare signals between wild-type and crlk1 knockout plants

    • Test specificity in complementation lines expressing CRLK1 under a native or heterologous promoter

    • Evaluate cross-reactivity with closely related kinases

  • Biochemical validation:

    • Perform peptide competition assays using the immunogenic peptide

    • Test antibody against recombinant CRLK1 protein

    • Compare results from different antibodies targeting distinct CRLK1 epitopes

  • Technical controls:

    • Omit primary antibody to assess secondary antibody background

    • Evaluate pre-immune serum (for polyclonal antibodies)

    • Test across multiple applications (Western, IP, IF) for consistent results

  • Sensitivity assessment:

    • Determine detection limits using titrated recombinant protein

    • Compare detection sensitivity across different applications

    • Evaluate performance with native versus denatured protein

  • Reproducibility testing:

    • Test batch-to-batch consistency

    • Validate across different experimental conditions

    • Verify results across multiple biological replicates

Proper validation is critical, as demonstrated in studies where CRLK1 immunocomplex analysis revealed several bands of different sizes only in wild-type but not in the crlk1 knockout mutant plants .

What are the remaining knowledge gaps in understanding CRLK1 function in cold signaling?

Despite significant progress, several important questions about CRLK1 remain unanswered:

  • Upstream regulators: The mechanisms by which cold stress activates CRLK1 and the identity of upstream components that regulate CRLK1 activity are not fully characterized.

  • Substrate specificity: While MEKK1 interaction has been established , the direct substrates of CRLK1 kinase activity and the specific residues it phosphorylates need further investigation.

  • Structural insights: The three-dimensional structure of CRLK1 and how calcium/calmodulin binding induces conformational changes that affect its activity remain to be determined.

  • Tissue-specific functions: The potential differential roles of CRLK1 in various plant tissues and developmental stages during cold stress responses require further exploration.

  • Species conservation: The extent to which CRLK1 function in cold signaling is conserved across different plant species, particularly between model plants and crops, needs additional research.

  • Temporal dynamics: The precise timing of CRLK1 activation in relation to other cold signaling events and how this timing affects downstream responses remains to be fully characterized.

Addressing these knowledge gaps will require the development of new antibody tools and experimental approaches to fully elucidate CRLK1's role in plant cold tolerance.

How can new antibody technologies advance CRLK1 research?

Emerging antibody technologies offer new opportunities for CRLK1 research:

  • Phospho-specific antibodies: Development of antibodies that recognize specific phosphorylated residues on CRLK1 would enable monitoring of its activation state in response to cold stress and other stimuli.

  • Nanobodies: Single-domain antibodies derived from camelids can access epitopes that conventional antibodies cannot reach, potentially revealing new aspects of CRLK1 structure and function.

  • Intrabodies: Antibodies engineered to function inside living cells could be used to track or modulate CRLK1 activity in real-time during cold stress responses.

  • BiTE (Bi-specific T-cell Engager) technology adaptation: Modified to target protein-protein interactions, this approach could allow selective disruption of specific CRLK1 interactions to determine their functional significance.

  • Proximity labeling antibodies: Antibodies conjugated with enzymes like APEX or BioID could identify transient or weak CRLK1 interactors in their native cellular environment.

  • Single-molecule imaging compatible antibodies: Highly photostable fluorophore-conjugated antibodies could enable super-resolution microscopy of CRLK1 dynamics during signaling events.

These advanced antibody technologies, when applied to CRLK1 research, could significantly accelerate our understanding of cold stress signaling mechanisms in plants.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.